{
    "2019-12-18": [
        [
            {
                "time": "",
                "original_text": "辉瑞、诺华、罗氏......跨国药企们2019年在中国都在做这3件事",
                "features": {
                    "keywords": [
                        "辉瑞",
                        "诺华",
                        "罗氏",
                        "跨国药企",
                        "中国",
                        "2019"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "复星凯特首个CAR-T产业化生产基地正式启用",
                "features": {
                    "keywords": [
                        "复星凯特",
                        "CAR-T",
                        "生产基地",
                        "启用"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2019-12-18",
                "original_text": "格隆汇个股放量排行榜 | 12月18日",
                "features": {
                    "keywords": [
                        "格隆汇",
                        "个股",
                        "放量",
                        "排行榜"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "复星医药(02196-HK)更换联席公司秘书及授权代表 董监高成员变化",
                "features": {
                    "keywords": [
                        "复星医药",
                        "联席公司秘书",
                        "授权代表",
                        "董监高",
                        "变化"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "港股开盘前瞻：晨兴资本出售2.4亿股小米 迈科管业等三新股首挂",
                "features": {
                    "keywords": [
                        "港股",
                        "晨兴资本",
                        "小米",
                        "迈科管业",
                        "新股",
                        "首挂"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技",
                        "工业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【民生医药|公司深度】复星医药：整合能力提升+创新增量催化，业绩迎来兑现期",
                "features": {
                    "keywords": [
                        "民生医药",
                        "复星医药",
                        "整合能力",
                        "创新增量",
                        "业绩",
                        "兑现期"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}